Facetten
Zugriff
Einrichtung
Medientyp
- Text 2
Karte
Erscheinungsjahr
- 2014 2
Autor/in
- Hanfstein, Benjamin
- Lauseker, Michael 2
- Müller, Martin C 2
- Pletsch, Nadine
- Proetel, Ulrike 2
- alle zeigen
Sprache
- Englisch 2
2 Einträge gefunden
-
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV
- Hehlmann, Rüdiger
- Müller, Martin C
- Lauseker, Michael
- Hanfstein, Benjamin
- Fabarius, Alice
- Schreiber, Annette
- Proetel, Ulrike
-
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV
- Proetel, Ulrike
- Pletsch, Nadine
- Lauseker, Michael
- Müller, Martin C
- Hanfstein, Benjamin
- Krause, Stefan W
- Kalmanti, Lida